AAAAAA

   
Results: 1-8 |
Results: 8

Authors: De Zilwa, SRN Emiris, I Uhm, JH Whitelaw, JH
Citation: Srn. De Zilwa et al., Combustion of premixed methane and air in ducts, P ROY SOC A, 457(2012), 2001, pp. 1915-1949

Authors: Cui, G Yoo, JH Lee, JS Yoo, J Uhm, JH Cha, GS Nam, H
Citation: G. Cui et al., Effect of pre-treatment on the surface and electrochemical properties of screen-printed carbon paste electrodes, ANALYST, 126(8), 2001, pp. 1399-1403

Authors: Levin, VA Uhm, JH Jaeckle, KA Choucair, A Flynn, PJ Yung, WKA Prados, MD Bruner, JM Chang, SM Kyritsis, AP Gleason, MJ Hess, KR
Citation: Va. Levin et al., Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazin N-(2-chloroethyl)-N '-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme, CLIN CANC R, 6(10), 2000, pp. 3878-3884

Authors: De Zilwa, SRN Uhm, JH Whitelaw, JH
Citation: Srn. De Zilwa et al., Combustion oscillations close to the lean flammability limit, COMB SCI T, 160, 2000, pp. 231-258

Authors: Uhm, JH Dooley, NP Kyritsis, AP Rao, JS Gladson, CL
Citation: Jh. Uhm et al., Vitronectin, a glioma-derived extracellular matrix protein, protects tumorcells from apoptotic death, CLIN CANC R, 5(6), 1999, pp. 1587-1594

Authors: Uhm, JH Shin, MY Zhidong, J Chung, JS
Citation: Jh. Uhm et al., Selective oxidation of H2S to elemental sulfur over chromium oxide catalysts, APP CATAL B, 22(4), 1999, pp. 293-303

Authors: Chintala, SK Kyritsis, AP Mohan, PM Mohanam, S Sawaya, R Gokslan, Z Yung, WKA Steck, P Uhm, JH Aggarwal, BB Rao, JS
Citation: Sk. Chintala et al., Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: Modulation of migration and invasion of human malignant glioma cells, MOL CARCINO, 26(4), 1999, pp. 274-285

Authors: Uhm, JH Dooley, NP Stuve, O Francis, GS Duquette, P Antel, JP Yong, VW
Citation: Jh. Uhm et al., Migratory behavior of lymphocytes isolated from multiple sclerosis patients: Effects of interferon beta-1b therapy, ANN NEUROL, 46(3), 1999, pp. 319-324
Risultati: 1-8 |